Abeona Therapeutics Inc.
ABEO • NASDAQ
Abeona Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Vishwas Seshadri, with a market cap of $244.7M.
CEOVishwas Seshadri
Next Earnings
Upcoming earnings announcement for Abeona Therapeutics Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.37
Revenue Estimate
$5.6M
Earnings History
Past 12 earnings reports for Abeona Therapeutics Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.34Est: -$0.36 | +5.6% | $5.4MEst: $4.9M | +10.2% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.10Est: -$0.31 | +67.7% | -Est: $5.5M | -100.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | $1.71Est: -$0.39 | +538.5% | -Est: $21.7M | -100.0% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.24Est: -$0.37 | +35.1% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.14Est: -$0.34 | +58.8% | -Est: $83.3K | -100.0% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.63Est: -$0.40 | -57.5% | -Est: $100.0K | -100.0% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.26Est: -$0.36 | +27.8% | -Est: $80.0K | -100.0% | 10-Q |
| May 15, 2024 | Q1 2024 | -$1.16Est: -$0.53 | -118.9% | -Est: $250.0K | -100.0% | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$0.64Est: -$0.47 | -36.2% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.48Est: -$0.52 | +7.7% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.92Est: -$0.68 | -35.3% | $3.5M | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.54Est: -$0.61 | +11.5% | - | — | — |